MindMaze

📍 Lausanne, Switzerland🗓 Founded 2012👥 157 employees💰 Last funded Oct 2021
Biotechnology Research🌐 mindmaze.com
Website LinkedIn
MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brains ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMazes pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2012
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2017–2021 · investors recorded per year
201712019120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in MindMaze?
MindMaze has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did MindMaze last raise funding?
The most recent investment in MindMaze recorded on gritt.io was in October 2021.
When was MindMaze founded?
MindMaze was founded in 2012.
What industry is MindMaze in?
MindMaze operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MindMaze based?
MindMaze is headquartered in Lausanne, Switzerland.